Oruka Therapeutics (ORKA) Free Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | -13.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.26% |
| Dec 31, 2025 | -20.37% |
| Sep 30, 2025 | 22.00% |
| Jun 30, 2025 | -109.96% |
| Mar 31, 2025 | -12,329.76% |
| Dec 31, 2024 | -1,683.71% |
| Sep 30, 2024 | -1,566.75% |
| Jun 30, 2024 | -1,489.77% |
| Mar 31, 2024 | 89.47% |
| Dec 31, 2023 | 29.32% |
| Sep 30, 2023 | 33.19% |
| Jun 30, 2023 | 73.53% |
| Mar 31, 2023 | 62.91% |
| Dec 31, 2022 | 69.84% |
| Sep 30, 2022 | 49.00% |
| Jun 30, 2022 | 29.61% |
| Mar 31, 2022 | 17.75% |
| Dec 31, 2021 | -64.69% |
| Sep 30, 2021 | -144.66% |
| Jun 30, 2021 | -256.46% |
| Mar 31, 2021 | -209.53% |
| Dec 31, 2020 | -159.31% |
| Sep 30, 2020 | -125.70% |
| Jun 30, 2020 | 12.18% |
| Mar 31, 2020 | -7.85% |
| Dec 31, 2019 | 13.63% |
| Sep 30, 2019 | 43.83% |
| Jun 30, 2019 | 47.20% |
| Mar 31, 2019 | 49.02% |
| Dec 31, 2018 | 68.00% |
| Sep 30, 2018 | 60.27% |
| Jun 30, 2018 | 54.54% |
| Mar 31, 2018 | 29.28% |
| Dec 31, 2017 | -9.13% |
| Sep 30, 2017 | -6.20% |
| Jun 30, 2017 | -40.57% |
| Mar 31, 2017 | -11.84% |
| Dec 31, 2016 | -46.68% |
| Sep 30, 2016 | -55.66% |
| Jun 30, 2016 | -46.71% |
| Mar 31, 2016 | -24.69% |
| Dec 31, 2015 | -38.51% |
| Sep 30, 2015 | -15.74% |
| Jun 30, 2015 | -36.36% |
| Mar 31, 2015 | 15.51% |
| Dec 31, 2014 | -0.91% |
| Sep 30, 2014 | -23.12% |
| Jun 30, 2014 | -79.17% |
| Mar 31, 2014 | -376.97% |
| Dec 31, 2013 | -180.00% |
| Sep 30, 2013 | -117.68% |
| Jun 30, 2013 | -0.72% |
| Mar 31, 2013 | 53.32% |
| Dec 31, 2012 | 46.57% |
| Sep 30, 2012 | 53.76% |
| Jun 30, 2012 | 53.63% |
| Mar 31, 2012 | 14.68% |
| Dec 31, 2011 | -9.62% |
| Sep 30, 2011 | 16.70% |